Lowering bad cholesterol reduces heart risks — no matter how you do it

Original Title

Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

Scientists looked at many studies and found that lowering LDL cholesterol by 1 unit cuts heart risks by about 23%, whether using statins or other pills that work the same way.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

Nonstatin therapies like ezetimibe and bile acid sequestrants reduced heart risk just as much as statins per unit of LDL-C lowered.

Many assume statins have unique anti-inflammatory or plaque-stabilizing benefits beyond cholesterol-lowering—but this study suggests their power comes mostly from LDL reduction alone.

Practical Takeaways

If you're on a nonstatin therapy like ezetimibe or a bile acid sequestrant, don't assume it's weaker—focus on how much LDL you lower, not which drug you take.

low confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.

52%
Moderate QualityOverall Score

Publication

Journal

JAMA

Year

2016

Authors

Michael G. Silverman, B. Ference, K. Im, S. Wiviott, R. Giugliano, S. Grundy, E. Braunwald, M. Sabatine

Open Access
1277 citations
Analysis v1